Alnylam Pharmaceuticals
ALNY
#814
Rank
NZ$53.63 B
Marketcap
NZ$400.86
Share price
0.23%
Change (1 day)
-47.04%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company